(±)-10,11-Dihydro-10-Hydroxycarbamazepi
|
|
|
?UA,2S – GalNAc,6S (diD)
|
|
|
1,2,3,4-Tetrachloro[13C12]dibenzofuran
|
|
|
1,3,6,8-Tetrachloro[13C12]dibenzofuran
|
|
|
1,2,3,4,6-Pentachloro[13C12]dibenzofuran
|
|
|
1,2,3,4,7,8-Hexachloro[13C12]dibenzo-p-dioxin
|
|
|
1,2,3,4,6,8,9-Heptachloro[13C12]dibenzofuran
|
|
|
0.45 μm 96-Well Filter Plate
|
|
|
(1,3-Bis(1-ethoxyethyl)-1H-pyrazol-4-yl)boronic acid pinacol ester
|
|
|
[Pyr3]-beta-Amyloid (3-42), Human
|
|
|
(R)-Remdesivir (D-Alanine isomer)
|
|
|
[Cys26]-beta-Amyloid (1-42), S26C beta-Amyloid (1-42), Human
|
|
|
(1R,3S,4S)-tert-Butyl 3-(5-(4-bromophenyl)-1H-imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate
|
|
|
(R)-Remdesivir-d5
|
|
|
[Lys(Ac)40]-Ac-a-Tubulin (29-50)-WGK(Biotin), TubK40(Ac)-WGK, biotin-labeled
|
|
|
(S)-Hydroxychloroquine-d5
|
|
|
[Cys(HiLyte? Fluor 647 C2 maleimide)]-Exendin-4
|
|
|
(S)-(2-(1-(tert-Butoxycarbonyl)pyrrolidin-2-yl)-1H-benzo[d]imidazol-6-yl)boronic acid pinacol ester
|
|
|
(S)-N-(3-Methoxybenzyl)-1-(1-(naphthalen-1-yl)ethyl)piperidine-4-carboxamide
|
|
|
?UA – GlcNAc
|
|
|
(+\-)-BDB hydrochloride (3,4-Methylenedio
|
|
|
(R)-Remdesivir-d4
|
|
|
(±)-Opc-8-D5
|
|
|
(S)-tert-Butyl 2-(6-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-benzo[d]imidazol-2-yl)pyrrolidine-1-carboxylate
|
|
|
(±)-cis-11-Nor-9-carboxy-Δ9-THC-D3 gluc
|
|
|
[13C3]-2,3-DPG sodium salt
|
|
|
[2H5]-L-His-L-TRP
|
|
|
0.45 μm filter mini column with 2 mL tubes with lid
|
|
|
(S)-5-tert-butyl 6-ethyl 5-azaspiro[2.4]heptane-5,6-dicarboxylate
|
|
|
(1,5-Bis(1-ethoxyethyl)-1H-pyrazol-4-yl)boronic acid pinacol ester
|
|
|
0.22 μm filter mini column with 2 mL tubes with lid
|
|
|
13C Labelled asialo, agalacto triantennary (A3G0(3))
|
|
|
13C Labelled asialo, agalacto biantennary core-substituted with fucose (G0F)
|
|
|
14(S)-HDHA MaxSpec? Standard
|
|
|
13C Labelled asialo, galactosylated tetraantennary complex N-glycan, with one unit of N-acetyllactosamine (A4-LacNAc-G4)
|
|
|
13C Labelled mono-sialylated, galactosylated biantennary, core-substituted with fucose (G2A1(6)FSial2,6)
|
|
|
13C Labelled asialo, monogalactosylated biantennary complex N-glycan (G1(3))
|
|
|
1-Azido-1-deoxy-β-D-Glucopyranoside (Peracetate)
|
|
|
13C Labelled di-sialylated, galactosylated biantennary, core-sub w/ fucose, w/ bisecting GlcNAc (bA2F 2x Sial 2,6)
|
|
|
13C Labelled mono-sialylated, mono-galactosylated biantennary, core-substituted with fucose (A1(6)Sial2,3)
|
|
|
13C Labelled mono-sialylated, galactosylated biantennary, core-substituted with fucose (G2A1(6)FSial2,3)
|
|
|
13C Labelled mono-sialylated, mono-galactosylated biantennary complex N-glycan (A1(3)Sial2,3)
|
|
|
13C Labelled asialo, agalacto, biantennary complex N-glycan, with bisecting GlcNAc (bG0)
|
|
|
16S V1-V2 Amplicon PCR Kit (Indexes Set 1-96)
|
|
|
13C6-Glucosylsphingosine
|
|
|
13C Labelled asialo, galactosylated triantennary, core-substituted with fucose (A3G3F)
|
|
|
13C Labelled mono-sialylated, galactoyslated biantennary complex N-glycan (G2A1(3)Sial2,3)
|
|
|
13C Labelled mono-sialylated, galactoyslated biantennary complex N-glycan (G2A1(3)Sial2,6)
|
|
|
13C Labelled asialo, monogalactosylated biantennary core substituted with fucose (G1F)
|
|
|
13C Labelled asialo, monogalactosylated biantennary complex N-glycan (G1(6))
|
|
|
13C Labelled oligomannose 3 (Man-3)
|
|
|
13C Labelled asialo, galactosylated biantennary complex N-glycan (G2)
|
|
|
1-Hydroxypyrene Urine Calibration Standard
|
|
|
13C Labelled asialo, agalacto truncated biantennary with core fucose (MGn(3)F)
|
|
|
13C Labelled asialo, galactosylated tetraantennary core-substituted with fucose, with one unit of N-acetyllactosamine (A4-LacNAc-G4F)
|
|
|
17α-Hydroxypregnenolone-20,21-13C2,16,16-d2 ≥98 atom %, ≥98% (CP)
|
|
|
13C Labelled di-sialylated, galactosylated biantennary complex N-glycan (A2, 2xSial2,3)
|
|
|
13C Labelled asialo, agalacto biantennary complex N-glycan (G0)
|
|
|
13C Labelled asialo, galactosylated biantennary core-substituted with fucose (G2F)
|
|
|
13C Labelled asialo-, agalacto-, tetraantennary complex N-glycan (A4)
|
|
|
1-Hydroxypyrene Urine Control, Level II
|
|
|
13C Labelled di-sialylated-, galactosylated biantennary, core-substituted with fucose (A2F 2xSial2,6)
|
|
|
13C Labelled asialo, agalacto truncated biantennary (MGn(6))
|
|
|
13C Labelled oligomannose 5 (Man-5)
|
|
|
13C Labelled asialo, agalacto triantennary, core-substituted with fucose (A3G0(3)F)
|
|
|
1-Hydroxypyrene Urine Control, Bi-Level (I + II)
|
|
|
1-Hydroxypyrene Urine Control, Level I
|
|
|
2 | Plant Cell Compartment Antibody Marker Set | 5 antibodies
|
|
|
1X Phosphate Buffer Solution
|
|
|
1st International Reference Panel for Anti-SARS-CoV-2 Immunoglobulin
|
|
|
1-Palmitoyl-2-stearoyl-rac-glycero-3-phosphocholine (trimethyl-d9) 98 atom % D, 97% (CP)
|
|
|
1X RNA Loading Buffer, 0.5 mL
|
|
|
2,3,3',4,4'-Pentachloro[13C12]biphenyl
|
|
|
2,3,3',4,4',5,5',6-Octabromo[13C12]diphenyl ether
|
|
|
2,2',4,4',5,5'-Hexabromo[13C12]biphenyl
|
|
|
2,2',3,3',5,6-Hexachloro-4-methoxybiphenyl
|
|
|
2,2',3,4,4',5,5'-Heptabromo[13C12]diphenyl ether
|
|
|
2,2',3,3',4',5,6-Heptachloro-4-methoxybiphenyl
|
|
|
2,2',3,3',5,6,6'-Heptabromodiphenylether
|
|
|
2,3,7,8-[37Cl4]-Tetrachlorodibenzo-p-dioxin
|
|
|
2378-TCDDIsomerSpecificityTestMixture forDB-5,BP5,HP-2,Rtx-5,SPB-5, orEquivalentColumns
|
|
|
25-OH-Vitamin D3/D2 in Serum/Plasma (Online Method) - HPLC
|
|
|
25-OH-Vitamin D3/D2 Serum Control, Bi-Level (I+II)
|
|
|
25-OH-Vitamin D3/D2 Serum Control, Level I
|
|
|
25-OH-Vitamin D3/D2 Serum Control, Level II
|
|
|
3,3',4,4',5,5'-Hexabromo[13C12]diphenyl ether
|
|
|
2X One-Step RT-PCR Master Mix
|
|
|
3,3',4,5'-Tetrachloro[13C12]biphenyl
|
|
|
2-O desulphated heparin oligosaccharides dp12
|
|
|
2-Perfluorohexylethanoicacid(6:2)
|
|
|
2-Perfluoro decyl ethanoicacid(10:2)
|
|
|
3'-Sialyl-tri-N-acetyllactosamine-PEG3-Biotin (Single Arm)
|
|
|
3PLUS1? Multilevel Plasma Calibrator Set Amino Acid Analysis
|
|
|
3PLUS1? Multilevel Plasma Calibrator Set Methylmalonic Acid
|
|
|
3'-Glyceryl-CPG1000
|
|
|
3-Perfluoro heptyl propanoicacid(7:3)
|
|
|
3'-Thiol-Modifier-C3-SS-CPG1000
|
|
|
488 Goat-anti-Rabbit IgG
|
|
|
4-Androstene-3,17-dione-2,3,4-13C3 solution 0.1?mg/mL in methanol, 98 atom % 13C, 98% (CP)
|
|
|
4-Fluoro-D-Glucosamine (HCl Salt)
|
|
|